How I’m Playing The Red-Hot Small-Cap Biotech Stocks
May 17, 2020 at 03:54 AM EDT
Government provided liquidity has lifted all boats and removed (most of) the funding risk for dev stage biotechs. At the same time there is a recognition by investors that many biotech firms are not going to see a material impact from the pandemic.